MED3000
MED3000 is focused on the development of healthcare management and technology solutions and services. Its products focus on billing and RCM, EHR, EMR, practice management, proactive patient outreach, coding and compliance, and patient portals. MED3000 was acquired by McKesson in October 2012. MED3000 was founded in 1995 and is based in Pittsburgh, Pennsylvania.
MED3000
Industry:
Health Care
Founded:
1995-01-01
Address:
Pittsburgh, Pennsylvania, United States
Country:
United States
Website Url:
http://www.med3000.com
Total Employee:
5001+
Status:
Closed
Contact:
412-937-8887
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Domain Not Resolving Mobile Non Scaleable Content Microsoft Exchange Online Amazon Office 365 Mail ReCAPTCHA
Similar Organizations
Magellan Healthcare
Magellan Healthcare is a specialty healthcare management services company.
Nexus Pharmaceuticals
Nexus Pharmaceuticals, a US-based, privately-held healthcare company.
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2006-07-28 | iLIANT | iLIANT acquired by MED3000 | N/A |
Official Site Inspections
http://www.med3000.com
- Host name: 208.70.69.95
- IP address: 208.70.69.95
- Location: Pittsburgh United States
- Latitude: 40.5024
- Longitude: -79.949
- Metro Code: 508
- Timezone: America/New_York
- Postal: 15223
More informations about "MED3000"
Healthcare Provider Services | MED3000 of the Virginias
Sep 29, 2021 · Improve your medical practice’s cash flow with MED3000’s Billing and Revenue Cycle Management services. We help maximize your revenue with customizable services including billing, reporting, software management, …See details»
About Us | Med3000 of the Virginias
MED3000 offers healthcare provider services ranging from revenue cycle management to HR outsourcing to complete physician integration. For 20 years, we have helped healthcare providers remain independent by supporting their …See details»
MED3000 - Crunchbase Company Profile & Funding
MED3000 is focused on the development of healthcare management and technology solutions and services. Its products focus on billing and RCM, EHR, EMR, practice management, …See details»
FDA grants OTC marketing clearance to topical gel for …
Jun 16, 2023 · Clinical research has demonstrated a 10-minute onset interval for the topical gel formulation MED3000, compared to an interval of at least 30 minutes with PDE5 inhibitors, such as Cialis and Viagra.See details»
MED3000 - Crunchbase Company Profile & Funding
MED3000 offers healthcare provider services ranging from revenue cycle management to HR outsourcing to complete physician integration.See details»
US FDA Grants for Over-the-Counter Marketing
Jun 12, 2023 · MED3000 can now be legally marketed in the USA as the first topical treatment available OTC without the need for a prescription. MED3000 is approved as an effective, clinically proven treatment...See details»
Practice Management Consulting | Med3000 of the Virginias
MED3000 supports the success of your practice, handling all of the details – financial, operational and human resources. When MED3000 is providing practice management consulting, you can …See details»
Haleon to commercialise MED3000 in the US - Trinity Delta
Jul 17, 2023 · The deal grants Haleon exclusive rights to commercialise MED3000 (Eroxon in Europe) across the USA, with Haleon responsible for the launch (although no detail on likely …See details»
US regulatory and commercial update for MED3000
Dec 20, 2021 · Futura Medical plc (AIM: FUM), a pharmaceutical company developing a portfolio of innovative products for sexual health and pain relief, is pleased to provide an update on …See details»
Pre-launch of MED3000 ahead of H1 2023 launch – Company …
MED3000 is the first pan-European topical treatment for ED available without the need of a doctor's prescription and available over the counter ("OTC"). Subject to US Food and Drug...See details»
FDA approves new over-the-counter gel for erectile …
Sep 1, 2023 · In June, the FDA approved the over-the-counter sale of MED3000 (Eroxon), a topical gel treatment for ED. MED3000 is supplied in single-use tubes. The contents are rubbed onto the head of the penis immediately before sexual …See details»
FDA regulatory and commercial update for MED3000
Jul 19, 2021 · MED3000 is Futura's topical gel formulation that is a breakthrough treatment for erectile dysfunction (ED) through a unique evaporative mode of action. Futura has conducted …See details»
PD52-07 EFFICACY AND SAFETY OF MED3000, A NOVEL TOPICAL …
MED3000 met the MCID for improving erectile function with a favorable safety profile. This novel topical agent may be useful for men with ED who are not candidates for a PDE5 inhibitor, who …See details»
MED3000 gel: Favorable responses seen on sexual encounter …
Oct 18, 2024 · MED3000 gel is FDA-cleared for over-the-counter use and improves erectile dysfunction outcomes for men and partners. A 12-week study across multiple countries …See details»
MED3000 on course for OTC approval in Europe and US
Sep 16, 2020 · The key developments with MED3000, its novel treatment for erectile dysfunction (ED), suggest that European OTC approval is likely during 2021 and in the US, pending a …See details»
MED3000, Inc. - Facebook
MED3OOO is a leader in the healthcare management and technology field offering a broad range of services and solutions.See details»
Significant achievements position MED3000 for success
Sep 18, 2023 · Success in the US or EU could be transformational MED3000 is the first clinically proven topical ED treatment available OTC in both the US and Europe. Given its rapid onset, …See details»
(314) MED3000, A CLINICALLY PROVEN, FAST-ACTING TOPICAL …
Jul 6, 2023 · MED3000 has been shown to deliver a clinically meaningful response and is fast-acting. It was also shown to be clinically effective in mild, moderate and severe ED. Results …See details»
MED3000 continues to progress towards first sales - Trinity Delta
Dec 13, 2022 · First marketing authorisations have now also been granted for Eroxon (MED3000) in three countries in the Middle East, including the United Arab Emirates. Further approvals …See details»
Topical gel shows promise for erectile dysfunction in phase 3 …
Sep 2, 2022 · FM71 is a multi-center, randomized, open-label, home use, parallel group, clinical investigation of topically-applied MED3000 gel compared to oral tadalafil (5mg) tablets for the …See details»